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A b s t r a c t  
The aim of our study was to utilize novel foam granulation technique in formulation of miconazole 
nitrate; a model hydrophobic drug as oral disintegrating tablets "ODT" particularly to enhance its 
bioavailability. Foam granulation technique has additional advantages over the other traditional 
granulation technique since; it enhances the granulation process and produce acceptable tablets. 
Fractional factorial design was used to investigate the effect of formulation and processing variables 
on the prepared miconazole ODT. The prepared granules were evaluated by measuring their 
density, flowability, granules size and shape, and granules wetting time. The quality attributes of the 
prepared tablets; drug content, tablet thickness, uniformity of weight, tablet tensile strength, friability, 
disintegration, and dissolution were also evaluated. The results indicated that, the prepared granules 
showed acceptable characteristics and is significantly affected by the disintegrant type, urea 
concentration, and the lubricant type. The quality attributes of the tablets were not affected by the 
processing parameters. From the prepared formulas; F20, F19, F12, and F20 displayed 18, 35, 35, 
and 40 seconds disintegration time respectively and the percent of dissolution after 15 minutes 
ranged from 94.4-100%. These results ascertained that foam granulation technique fulfill the 
requirement in preparation of miconazole ODT. 




Foam granulation is a relatively new technique developed by Dow 
Chemical Company in early 2000s [1]. The technique involves 
incorporation of air into conventional water-soluble polymeric 
excipients in which the binder solution is supplied in the form of 
foam rather than solution or spray resulting in foam has a 
consistency like shaving cream. In a small-scale laboratory setting 
or in a full-scale production setting, the foam generator can be 
connected directly to high-shear, low-shear, or fluid bed 
granulation equipment [2]. Adding the binder solution as foam 
rather than a spray eliminates the problem related to conventional 
techniques such as overwetting that can cause the powder to 
cake in the equipment, inconsistent and unpredictable binder 
distribution that can affect tablet hardness and drug release, and 
finally clogged spray nozzles that may exacerbate the situation.  
The technique offers additional benefits such as improves 
distribution of the binder, reduces the amount of binder required, 





binder addition, and makes mixing of binder and powder more 
efficient [1].  
Dysphagia; the symptom of difficulty in swallowing is reported in 
about 35% of the general population, as well as up to 60% of the 
elderly institutionalized population and 18-22% of all patients in 
long-term care facilities [3]. So, oral disintegrating tablets (ODT) 
were developed to be more convenient to use and to address 
potential issues of patient compliance. ODT are designed to 
disintegrate or dissolve rapidly on contact with saliva, thus 
eliminating the need to chew the tablet, swallow an intact tablet, 
or take the tablet with liquids. ODT could be used as drug delivery 
system for immediate release products as well as sustained 
release products [4]. 
Miconazole is an antifungal drug that inhibit the 
enzyme cytochrome P450 CYP51 14α-demethylase; the enzyme 
necessary to convert lanosterol to ergosterol. Depletion of 
ergosterol in fungal membrane disrupts the structure and many 
functions of fungal membrane leading to inhibition of fungal 
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drug intensive hepatic transformation that results in poor oral drug 
bioavailability (25-30%) hinders its use for systemic treatment via 
gastro intestinal tract. Miconazole peak plasma concentrations of 
about 1 mcg/ml have been achieved 4 hours after a dose of 1 g 
[6].  
 
The purpose of this work was to develop an oral dispersible tablet 
of miconazole nitrate as a model water-insoluble drug by relatively 
new foam granulation technique. This formulation might give a 
lead to an alternative route of administration of the drug through 
much easier granulation process.  
Materials and Methods 
Materials 
Miconazole nitrate USP32 was obtained from Sharon Biomedicine 
Ltd (Mumbai, India). Mannitol USP32 direct compression grade 
was purchased from Roquette (Lestrem, France). Microcrystalline 
cellulose (Avicel PH101) and Croscarmellose sodium (Ac-Di-sol) 
from FMC International (Wallingstown, Little Island Co. Cork, 
Ireland). Hydroxypropyl Methylcellulose from BASF Company 
(Ulm, Germany). Urea analytical grade; Sodium Starch glycolate 
(Explotab low pH & high pH) from JRS (Rosenberg, Germany). 
Crospovidone (Plasdone XL10) from ISP (Baar, Switzerland). 
Colloidal silicon dioxide (Aerosil 200, 300, 380 and R972), from 
Evonik (Frankfurt, Germany). Sodium Lauryl sulfate, from Fisher 
Scientific (Pittsburg, PA, USA). Magnesium stearate from Kirsch 
pharma company (Salzgitter, Germany). F D Green No. 3 (Fast 
green color) from Univar (Cheschire, UK). Methanol HPLC far UV 
and Acetonitrile HPLC far UV from Merck Chemicals Co. 
(Darmstadt, Germany) and Ammonium acetate from Panreac 
Quimica SA (Barcelona, Spain). 
 
All the above materials were in analytical grade and were used 
without further purification. 
 
Methods 
Estimation of possible interaction between miconazole 
nitrate and added excipients  
 
Miconazole nitrate was mixed with the fillers, super-disintegrants, 
sublimable agent,  glidant, lubricant and binder in which the 
compatibility of miconazole nitrate with these tablet excipients 
have been proven by the following: 
 
Differential scanning calorimetry (DSC) 
Samples of miconazole nitrate and binary blends of the drug with 
the studied excipients were scanned using DSC, ambient type 
apparatus (Perkin Elmer Corp., USA). The blending ratio was 
determined based on the common drug: excipients ratio (1:1 in 
case of fillers, binder and subliming agent, 1:0.5 in case of 
disintegrant, and 10:1 was used for drug/ lubricant and glidant).  
 
Fourier transform infrared spectroscopy (FTIR) 
All the materials used in the DSC study were tested in this 
section. The scanning was performed within the range 4000–500 
cm−1 using Nicolet is 10, IR spectrometer (Thermo Scientific, 
USA). The samples were kept in closed vials under stress 
conditions (14 days at 50º C).  
 
Design of the optimization program 
Taguchi optimization program was used to identify the critical and 
key factors that affect the performance of ODT.  A mixed-level, 
L32 Orthogonal array had been chosen. The design characteristics 
(responses) were determined. Development of optimization 
program involves; identification of the product formulation, 
determination of the formulation quality characteristics 
(responses) and selection of variables and their levels.  
 
Identification of the product formulation 
The preliminary trials revealed that miconazole nitrate can be 
formulated using foam granulation process. Mannitol/MCC was 
used as fillers, HPMC as a foamy binder, urea as sublimable 
agent, aerosil as glidant and magnesium stearate or sodium lauryl 
sulfate as lubricant. The superdisintegrant was chosen to be one 
of the following; croscarmelose sodium, sodium starch glycolate 
type A or type B and plasdone XL. 
 
Determination of the Quality characteristics 
(responses) 
Foam quality characteristics, Un-lubricated granules 
characteristics (densities, granule size & shape), Lubricated 
granules characteristics (flowability and wetting time), and routine 
quality control (QC) tests for tablet (drug content, surface 
scanning,  thickness, uniformity of weight, tablet tensile strength , 
friability, disintegration time, and dissolution rate) were selected to 
be studied. In addition; in-vivo disintegration time, tablet wetting 
time, water absorption ratio, and SEM micrographs of the tablet 
surface were also studied.  
 
Selection of variables and their levels 
Nine design variables were considered the most critical variables 
that are needed to be optimized; six variables related to the 
formula and three variables related to the process; the urea 
concentration, type and concentration of disintegrant, intra-
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granular disintegrant concentration, mannitol/ microcrystalline 
cellulose ratio, lubricant type, aerosil grade, impeller speed, 
milling conditions and tablet hardness.  
 
According to the previously stated factors for the development of 
the optimization program, 32 formulas were proposed as 
illustrated in table (1).  
Foam quality characterization  
Foam quality "FQ" is defined as the fraction of air contained in the 
foam and could be calculated according to the following equation 
[7]: 
FQ= [Vg / (Vg + Vl)] x 100 
Where Vg is the volume of gas and Vl is the volume of the liquid 
binder. 
 
Increasing the air fraction result in increasing the foam quality and 
the resultant foam are considered relatively stable. The foam 
quality was measured by using modified Tan and Hapgood 
method, 10 ml foam was pumped in a 10 ml measuring cylinder at 
room temperature, and the collapse of foam was measured after 
10 minutes [7]. 
 
Granulation process 
Mixing and granulation processes were carried out using 
Laboratory scale high shear double jacketed granulator (Chitra, 
India), which is equipped with three bladed impeller of plough like 
shape fixed in the bottom of the pot; the impeller operates at 
variable speed and is equipped with chopper that is fixed in the 
lid. The impeller speed and milling parameters were adjusted 
according to the pre-determined factors illustrated in table (1). The 
granulating liquid (HPMC/Urea in water) quantity was fixed (35% 
w/w of the total dry mass). After 5 minutes of starting the 
granulation process, the granulating liquid was pumped through 
the foam generating pump and the chopper was operated at fixed 
speed of 800 rpm. The obtained wet granules were dried using 
vacuum oven, (Binder, Germany) at 70-80 ºC, - 800 mbar till the 
loss on drying reach less than 2%, measured by moisture 
analyzer apparatus (Mettler Toledo, Switzerland). The dried 
agglomerates were weighed to calculate the product yield, milled 
and characterized.  
Characterization of granules 
Measurement of granules densities 
The different types of densities were measured to assess the 
granules flow properties. Bulk density is the mass of the granules 
divided by the packing volume. The bulk (DB) and tapped (DT) 
densities was determined using measuring cylinder tapping 
procedure. A sample of 100 ml of the granules was poured in a 
measuring cylinder and the weight of the poured volume was 
recorded after taping a measuring cylinder 500 times from a 
height of ~ 1.5 inch [8]. 
 
Flowability parameters 
The flowability of the granules was evaluated by the following 
methods: 
 
Carr's index  
Many factors affect the powder flowability including powder 
cohesiveness, particle size and size distribution. Carr described 
the flow rate by indirect method via the following equation:  
  Ci = 100 x (DT – DB) / DT  
Where Ci is the Carr's index, DT is the tapped density and DB is 
the bulk density [9]. 
  
Flow rate 
Granules flow rate was assessed using a flowmeter consisting of 
a funnel (12 cm diameter at top and 0.9 cm diameter at the efflux 
tube) that is fixed at pre-determined height to a Fritsch shaker to 
get precise vibration.  50 g sample of the granules was poured 
into the funnel and the powder flow rate through the funnel was 
determined as g/sec [10].  
 
Angle of repose 
Fixed height cone was utilized as a technique for measuring the 
angle of repose [10]. The flow rate, the diameter (D) and the 
height (h) of the formed heap were measured and utilized in 
calculation of the angle of repose according to the following 
equation:  Tan q = 2h/D 
Granules size and shape  
 
Volume surface mean diameter  "D43"  
The granules volume surface mean diameter "D43 was determined 
using Malvern mastersizer 2000 with dry cell (Malvern instrument, 
UK) and was calculated using Edmundson equation [11]:  
  D= [(∑ ndp+f) / (∑ ndf)] 1/p 
Where n is the number of particles in a size range, d is the 
average diameter of the particles in that range, p is an index 
related to the size of an individual particle, and f is a frequency 
index. 
 
Granules sample of 5-10 g were placed into the vibratory hopper 
of the Scirocco dry dispersion unit. The mass flow was adjusted 
until a stable and correct particle concentration was achieved at 2-
bar disperser pressure. 
 
Geometric standard deviation 
Samples of 50 g granules were placed in the top of a series of 
standard stainless steel sieve (Fritsch, Germany) of 710, 500, 
355, 250, 125, 75 and 45 micron. The vibration rate was adjusted 
to 40 and the process time was 10 minutes. The geometric mean 
diameter was calculated graphically from a log-probability plot of 
particle size versus percent cumulative weight undersize. 
Ahmed et al. International Journal of Drug Delivery 3 (4) 712-733 [2011] 
 
PAGE | 715 | 
 
 
Geometric mean standard deviation was calculated from 
geometric mean diameter data [11]. 
 
Elongation ratio 
The elongation ratio (ER) is a useful tool to assess the deviation 
from the spherical shape to an elongated form. Agglomerates 
shape was examined using an optical microscope connected to 
digital camera 1.3 megapixel, with magnification ratio 10-230 X 
and adjustable 8 LED fine tuned white light, connected to software 
that enables particle measurement (Chronos, Taiwan). 
Micrographs of these granules were captured and the length and 
breadth of the 20 particles were measured. The averages were 
calculated. The elongation ratio was calculated using the following 
formula: 
ER = b / L 
Where "b" is the length of major axis and "L" is the length of minor 
axis [12]. 
 
Granules wetting time 
Granules wetting time was assessed using the method previously 
described by Yadav et al [13]. Sample of 2 g granules were put in 
sintered glass funnel partially plunged (1 mm) into water. The time 
required for water capillary to rise up to the powder bed was 
measured. Few milligrams of fast green dye were put at the top of 
powder bed to help in accurate measure the granule wetting time.  
 
Compression of miconazole oral disintegrating tablets 
The glidant (Aerosil) and lubricant were added to the granules and 
mixed for 2 minutes using 5 liters capacity blender (Hualian, 
China). The lubricated granules were compressed to the pre-
specified tablet hardness using rotary press with variable speed 
(Karnavati Engineering Ltd, India) equipped with 8 mm diameter 
tools in which the tablet weight was adjusted to 200 mg. The 
rotary tablet press was run at low speed 5 rpm to guarantee 
accurate filling of the die. The compressed tablets were subjected 
to characterization.  
 
Characterization of tablets 
Visual inspection 
Upper and lower punches were inspected by naked eye for 
presence of sticking or picking. 
 
Drug content 
Ten tablets were weighed, ground and mixed in a mortar then this 
powder was sieved. Accurately weighed portion of the ground 
tablets equivalent to about 50 mg miconazole nitrate was 
dispersed in 25 ml of 50% methanol; the samples were filtered 
using syringe filter before subjecting to HPLC analysis using 
HPLC apparatus (Waters, USA). The mobile phase was prepared 
by dissolving 6 g Ammonium acetate in 1 liter of a mixture of 
acetonitrile, methanol and water in ratio 45:35:20 respectively, 
and filtered using nylon membrane filter 0.45 µm. Kromasil 100 
C18, 5 µm, (150 mm × 4.6 mm) column was used. The flow rate 
was adjusted to 1.5 ml/minute; the UV detector was adjusted to 
235 nm wave length. The injection volume was 20 µl. Different 
miconazole nitrate concentrations were prepared to construct 
drug standard curve by dissolving 50 mg of Miconazole nitrate in 
25 ml methanol. The method described in the USP for 
determination of the drug content was followed except for slight 
modification in the chromatographic conditions [14].   
 
Tablet thickness 
Tablet thickness was measured using dial thickness gauge 
(Mitutoya, Japan). Thickness measurement was performed 
directly after compression process. 
 
Uniformity of weight  
Uniformity of weight test was performed according to the method 
described in the USP [14]. 
 
Tablet tensile strength 
Hardness was determined according to standard method 
described in BP 2010 using tablet hardness tester (Pharmatest, 
Germany). The tablet tensile strength was calculated by using the 
following equation [15]: 
 
st = 2P/ [pDt] 
 
Where st is tablet tensile strength, P is fracture load in Newton, D 
is tablet diameter in cm and t is tablet thickness in cm [15]. 
 
Tablet friability 
Friability was determined according to standard method described 
in the USP using Friability tester (Pharmatest, Germany). 
 
In-vitro dissolution 
The dissolution of the prepared miconazole nitrate ODT was 
carried out using USP type I apparatus that has autosampler 
system based on peristaltic pump (Pharmatest, Germany) contain 
900 ml 0.45% w/w sodium lauryl sulfate and rotating at 75 rpm. 
Samples were withdrawn every 15 minutes and filtered. These 
were immediately replaced by equivalent volumes of freshly 
prepared 0.45% sodium lauryl sulfate. The amount of the drug 
released was measured spectrophotometrically using UV 
Spectrophotometer, 1650 PC (Schimadzu, Japan) at 230 nm. 
These conditions were selected to be in agreement with the 
dissolution of miconazole nitrate vaginal suppositories stated in 
the USFDA except for slight modification to make the process 
more  discriminating [16].  
 
Disintegration time 
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Disintegration was determined according to standard method 
described in USP34 using tablet disintegration test apparatus 
(Pharmatest, Germany). 
 
In-vivo disintegration time 
The in-vivo disintegration time of the tablets in the oral cavity was 
measured in healthy volunteers using the method described by 
Okuda, in which the tablet disintegration end point is the time for 
the tablet previously placed on the tongue had disintegrated until 
no lumps remained. The volunteer rinsed out their mouth with 
water before the test [17]. 
 
Tablet wetting time and water absorption ratio 
A piece of double folded tissue paper was placed in a petri dish 
containing 6 ml of water. One tablet was placed on this paper and 
the time for complete wetting of tablet was recorded. The wetted 
tablet was weighed and the water absorption ratio, R, was 
determined according to the following equation:  
 
R = 100 (Wa − Wb) / Wb 
 
Where Wb and Wa are the weights of tablet before and after 
water absorption, respectively [18]. 
 
Tablet surface scanning with SEM 
The morphological examination of the tablet surface was 
performed using scanning electron microscopy (SEM) (JOEl Ltd, 
Japan). Before microscopy, the tablets were mounted at carbon 
tape and were sputter-coated using gold. The photomicrography 
was taken at an acceleration voltage of 10 Kv at different 
magnification powers; 100X, 500X and 1000X [19]. 
 
Analysis and ranking 
The results were analyzed using Minitab 16th edition statistical 
software using analysis of Taguchi design function. The 
interpreting of the results was based on calculating the Delta 
statistics. The relative rank was based on the corresponding 
delta-value. The ranks indicate the relative importance of each 
factor to the response. Analysis of variance (ANOVA) was used to 
analyze the significance of the various variables on the 
responses. The variables were scored according to the effect on 
each response.  
Results and Discussions 
Estimation of possible interaction between miconazole 
nitrate and added excipients 
DSC chromatograms 
According to Figure (1), the DSC thermogram of plain miconazole 
nitrate showed characteristic endothermic peak at 183.9 °C 
represents the melting. Mixing the drug with the studied additives 
doesn't significantly affect the drug endothermic peak as indicated 
in the thermograms of the drug-additives physical blend. 
 
IR Spectroscopy 
The IR spectrum of miconazole nitrate showed a characteristic 
peaks at 1589, 1475 and 827 cm-1 which is in a good agreement 
with the work done by Barillaro et al who explained that the 
characteristic peak at 1589cm-1 is related to stretching of C-C 
bond of dichloro-substituted benzene ring, while the peak at 1470 
cm-1 is related to CH bending of the two dichlorobenzene groups 
and to the CH bending of the C6 and C17  [20, 21]. The peak at 
827 cm-1 may represent the C-H group of the Meta di-substituted 
benzene ring. The IR spectra of miconazole nitrate binary mixture 
with sodium lauryl sulfate showed the same characteristic peaks 
of the drug at 1589 and 827 cm-1 while the drug peak at 1475 cm-
1 was slightly shifted, whereas the IR spectrum of miconazole 
nitrate and mannitol showed the drug characteristic peaks at 1588 
and 1475 cm-1, while the peak at 827 cm-1 was also slightly 
shifted as illustrated in figure (2). The IR spectra for the other 
used additives (magnesium stearate, colloidal silicon dioxide, 
HPMC, plasdone XL, croscarmelose sodium, sodium starch 
glycolate type A and B, microcrystalline cellulose, and urea) don't 
show any shift or interference between the drug and studied 
substances.  
Characterization of foam quality  
The foam quality for the binder solution composed of HPMC and 
different percent of urea showed that, the binder solution with low 
urea content results in fine foam while the high urea content result 
in coarse foam. The foam quality percent was 84, 83, 82, and 59 
% respectively for 3, 6, 9, and 12 % urea. It is previously stated 
that, the foam quality for proper foam granulation should be 
around 90% and the higher the foam quality the narrow the nuclei 
size distribution [7]. Other reports mentioned also that, urea 
increases the surface tension of the aqueous solution [22]. The 
higher the foam quality, the longer the contact time between the 
foam and the powder to be granulated. This may result in better 
granulation process which results in more spherical granules. The 
statistical results for the significance of foam quality of different 
HPMC/urea solutions on the different properties of miconazole 
granules indicated that, the foam quality is significantly affecting 
the elongation ratio and granule wetting time. 
Characterization of granules 
Flowability parameters of granules: 
The bulk and tapped densities of the granules of different 
formulae were evaluated and the results were used in the 
calculation of Carr's index as displayed in table (2). The results of 
Carr's index were used as indicator of the flowability of the 
granules. It is obvious from the calculated Carr's index for the 
different formulae that the granules have moderate to poor 
flowability (Carr's index range 18 to 37 %) which could be 
improved by addition of glidant. The results of statistical analysis 
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for the effect of different variables (urea concentration, 
disintegrant type and concentration, intragranular disintegrant 
concentration, Mannitol / MCC, impeller speed and milling 
parameters) on Carr's index of miconazole un-lubricated granules 
indicated that, the disintegrant type affect the Carr's index 
significantly. Utilization of Plasdone XL10 produce larger granule 
size and hence increase the percent of fines in the powder which 
result in high Carr's index, this may be due to the large particle 
size of plasdone XL  (58 micron) compared with the particle size 
of croscarmelose sodium  (51 micron) or sodium starch glycolate 
(29 micron) [23]. The results showed also that, the granule 
densities and the Carr's index were not affected by the processing 
parameters. This indicates the ruggedness of the formula and 
process.  
Granules size and shape 
Volume surface mean diameter "D43" 
Statistical analysis of volume mean diameter D43 data shows that, 
the disintegrant type is the most important parameter that affects 
the volume surface mean diameter. The large particle size was 
produced by utilization of insoluble disintegrant "plasdone XL" 
while the other soluble disintegrants result in small particle size. 
This may be due to the large particle size of plasdone XL (58 
micron) compared to the particle size of croscarmellose sodium 
(51 micron) or sodium starch glycolate (29 micron). It is previously 
described that, initial particle size distribution has a strong effect 
upon granule growth rate and the mechanism by which wet 
granulation occurs [24]. The large particle size produced when 
plasdone were used may be also related to the difference in water 
uptake by the disintegrants. The total water added to each batch 
was constant at 35% regardless of the formulation. Plasdone 
adsorbs less water and hence allowing large granules to be 
formed. Croscarmellose adsorbs a lot of water, and so effectively 
there is less free liquid for granule formation.  
 
Geometric mean standard deviation 
Statistical analysis for the effect of different variables on 
geometric mean standard deviation of un-lubricated miconazole 
granules revealed that, the disintegrant concentration is the main 
factor that affects geometric mean standard deviation. 
 
Elongation ratio 
Specific software was used to calculate the length and width for 
each particle after microscopic imaging of the prepared granules 
in order to determine the elongation ratio. Formulae F1, F3 and 
F4 showed the highest elongation ratio (1.46, 1.48 and 1.48 
respectively). These formulae contain low urea content (3%). 
Figure (3) represents the microscopic graph of miconazole nitrate 
F19. The statistical analysis for the effect of different variables on 
elongation ratio of un-lubricated miconazole granules showed 
that, urea concentration affects the particle shape significantly, 
increasing the urea concentration results in more spherical 
granules and the effect of urea concentration reach a plateau 
level at 9 – 12%. The obtained results are in a good agreement 
with previous work emphasized that, the addition of urea 
increases the critical micelle concentration values of the 
surfactant [25]. The obtained results are also in a good agreement 
with previous work showed that, narrowest nuclei size distribution 
is obtained by granulating with high-quality foam [26]. It is 
reported that, elongation ratio of explotab is smaller than that of 
plasdone XL due to the spherical shape of explotab particles, 
while the plasdone XL particles are irregular in shape whereas, 
croscarmellose sodium particles have cylindrical shape which 
affects the resultant elongation ratio [23]. 
Flow rate of lubricated granules  
 
Table (3) summarizes the results of flow rate, angle of repose and 
wetting time of the lubricated granules. The flow rate was affected 
by lubricant type and glidant. Miconazole nitrate granules are 
hygroscopic since they contain high percentage of hygroscopic 
ingredients (urea and disintegrants). The presence of high 
percentage of hygroscopic materials in the granules may result in 
adsorption of moisture on the granules surfaces and increase of 
cohesion. Plasdone XL10 is less hygroscopic than croscarmellose 
sodium and sodium starch glycolate. Hydrophobic lubricant as 
well as hydrophobic glidant were more effective than hydrophilic 
ones in decreasing the powder cohesiveness. This may be 
explained by the presence of hydrophobic barrier on the granules 
surfaces that hinder the water bridging between granules. The 
obtained results consistent with previous results demonstrated 
that, hygroscopicity of formulation composition may increase the 
cohesive forces that result in poor powder flow in which the 
granule cohesiveness could be overcome by using hydrophobic 
stearate [27]. The presence of hydrophobic aerosil R972 in F5 
results in its good flow, while the presence of stearate in F24 
results in its good flow. The presence of 6% urea results in more 
spherical granules which enhance the flowability as previously 
mentioned. F1 did not contain hydrophobic glidant nor lubricant, 
but it contains low concentration of hygroscopic urea as well as 
relative low concentration of mannitol. Mannitol may exhibit crystal 
change during granulation process to needle shaped. The needle 
shaped crystals had poor flowability. It is hypothesized that, 
polymorphic transition of crystalline mannitol occurred during wet 
granulation process and the resultant filament-like mannitol 
crystals had good compressability properties as previously 
reported [28]. The poor flowability of F3 and F 11 may be due to 
absence of any hydrophobic ingredients in the formulae while, the 
poor flowability of F20 may be contributed to presence of high 
hygroscopic materials (3% urea and 12% croscarmellose sodium) 
and aerosil 380 (which surface area is almost twice than that of 
aerosil 200) and the poor flowability of F27 may be contributed to 
presence of high hygroscopic materials (9% urea and 12% 
plasdone) and high mannitol content. 
Angle of repose 
Angle of repose was affected significantly by lubricant type. The 
results of angle of repose were in a good agreement with the 
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results of flow rate and Carr's index. Hydrophobic aerosil and 
hydrophobic lubricant gave better flow than hydrophilic ones. The 
statistical analysis shows significant direct relationship between 
angle of repose and geometric standard deviation of the granules. 
The increase in geometric mean standard deviation results in 
particles interlocking and stacking which affect the angle of 
repose. This relationship is in agreement with previous work 
revealed that, the presence of fines in polydisperse powders 
increases the angle of repose and this may be due to interlocking 
of particles [29]. 
 
Granule wetting time 
Granule wettability was significantly affected by the lubricant type. 
The use of hydrophilic lubricant results in enhancing the granule 
wetting time. Sodium lauryl sulfate (SLS) facilitates uptake of 
water into the granules more rapidly than hydrophobic stearate 
which was previous stated in a study for the effect of various 
surfactants on the granules wettability [30]. These findings 
consistent also with previous results that indicated, SLS was more 
effective than other surfactants in promoting the wetting of 
hydrophobic drugs [31]. 
 
Characterization of the compressed tablets 
Visual inspection 
The compressed tablets show neither sticking nor picking. The 
punches were clean and the tablets logos were clear. 
 
Drug content  
The results of the drug content in the prepared compressed 
tablets is represented in table (4) which were within the range 
90.0 – 110 % which met the common pharmacopeias limit [14]. 
 
Tablet thickness 
Table (4) shows also the thickness of the compressed tablets 
which was used to calculate the tensile strength, the true density 
and the theoretical total tablet porosity. 
 
Uniformity of weight 
Table (4) shows the results of the weight variation. Statistical 
analysis for the effect of various parameters on tablet weight 
variation revealed that, variation in tablet weight is significantly 
affected by mannitol/MCC ratio. The increase in mannitol resulted 
in more weight variation which could be related to the moisture 
that induces polymorphic transition of crystalline mannitol [28]. 
The SEM micrographs of the tablets surfaces show that mannitol 
exhibited crystal change into needle shaped.  
 
Tensile strength 
Tablet tensile strength was significantly affected by urea 
concentration, aerosil type and lubricant type but these effects 
were not significant according to the statistical results obtained for 
the effect of various parameters on the tensile strength. The 
increase in urea concentration results in higher tensile strength of 
the produced tablets which may be explained by the ability of urea 
molecules to form hydrogen bonding between the molecules. One 
urea molecule is able to make 8 hydrogen bonding [32]. The 
results showed that the tensile strength was rugged enough so 
that it did not affected by change in the processing parameters 
(impeller speed and the milling parameters). 
 
Friability 
Tablets friability was significantly affected by tablet hardness. 
Increasing tablet hardness is a result of increasing the 
compression force which result in increasing the bonding of the 
granules and hence decreasing the tablet friability. 
 
Tablet wetting time and water absorption ratio 
Wetting time was significantly affected by disintegrant type and 
lubricant. Formulae F16, F24 and F32 showed the shortest tablet 
wetting time (26, 25 and 24 seconds respectively) while F7 
showed the longest tablet wetting time (165 seconds). F16, F24 
and F32 contain croscarmellose sodium as disintegrant, while F7 
contains plasdone XL as disintegrant. Croscarmellose sodium 
shows the shortest wetting time, followed by explotab low pH, 
explotab high pH while plasdone XL shows the longest wetting 
time. The filament structure of croscarmellose sodium aid in rapid 
uptake of water by tablets and hence enhancing the tablet wetting 
time.  The plasdone XL is insoluble disintegrant.  Zhao et al stated 
that significant reductions in the rate and extent of water uptake 
and swelling were observed for both sodium starch glycolate and 
croscarmellose sodium in an acidic medium (0.1N HCl), but not 
for plasdone XL [33]. The pH 20% miconazole nitrate aqueous 
solution was measured and the pH was 3.8 which indicate the 
acidity of the miconazole nitrate. Although croscarmellose sodium 
swelling capacity may decrease in the miconazole tablet 
microenvironment but still this swelling is more than that of 
plasdone XL (51 vs 33% respectively) [33]. 
 
The water absorption ratio is highly affected by urea concentration 
and tablet hardness. Urea is highly soluble that compete with the 
disintegrants on the adsorption of water. Formulae F20 and F2 
showed the highest water absorption ratio (143.1 and 85.5 
respectively) while F13 and F16 showed the smallest water 
absorption ratio (10.7 and 11.3 respectively) as illustrated in table 
(5). Although F2 is more hydrophilic than F20 due to lubricant 
nature, F20 showed superior water absorption ratio than F2, 
which may be explained by the presence of aerosil of larger 
surface area (aerosil 380 vs aerosil 300), presence of higher 
concentration of MCC (mannitol/MCC ratio 1:1 vs 2:1) and 
although explotab normally swells by 251% while croscarmellose 
swells only by 104% [33], the acidic microenvironment of 
miconazole nitrate tablets affect the swelling capacity of these 
disintegrants dramatically so that, explotab swells only by 43% 
and croscarmellose sodium swells by 51%. Previous work utilized 
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PEG/ urea to enhance the dissolution of miconazole nitrate using 
solid dispersion technique [34]. 
 
Calculated tablet total porosity  
Table (5) also shows the calculated true density and the 
calculated total porosity. In general, decreasing the tablet 
hardness increases the tablet porosity and hence gives the 
opportunity to the water to penetrate through the tablet surface 
pores and hence enhance the disintegration.  The achieved tablet 
total porosity was in the range 16-36%. The high porosity of F1 
may be explained by its low content of mannitol. Mannitol is 
compressed by plastic deformation and fragmentation [19]. The 
concentration of mannitol is adversely affecting the porosity of 
tablets. It is previously stated that, 30% porosity of ODT is 
desirable to get proper disintegration in the mouth [35].  
 
Disintegration time 
The disintegration time for all the studied formulas was below 180 
seconds as shown in table (5) which is the limit in the European 
pharmacopeia, while the disintegration of F12 tablets were below 
60 seconds which is the common limit in the USP. Rapid 
disintegration (≤ 35 seconds) was noticed in trial F13, F19 and 
F20. These formulae contain not less than 9% superdisintegrant 
and 50% of this concentration was added as intragranular 
disintegrant. All these formulae were compressed to get hardness 
35N or less. Formula 20 showed the fastest disintegration (18 
seconds) followed by F13 and F19 which showed 35 seconds. F 
20 contains: 12% croscarmelose sodium, Relative high content of 
MCC, and Hydrophilic aerosil 380. These ingredients may 
attribute to accelerating the disintegration of the tablets. The 
porous structure of the tablets (porosity was 30%) may also 
explain the high water absorption ratio and the short disintegration 
time. F13 and F19 have the same disintegration time (35 
seconds), the same tablet hardness and same disintegrant 
concentration. F13 has more hydrophilic surface than F19. This 
hydrophilicity is a result of presence hydrophilic glidant, 
hydrophilic lubricant and high concentration of urea. On the other 
hand F19 was characterized by higher total porosity (30% more 
than that of F13) and higher MCC content. MCC has 
disintegrating properties which may add positive effect to enhance 
the tablet wetting time and disintegration time. Tablet wetting time 
of F19 was 4 times faster than that of F13. Disintegration time is 
significantly affected by tablet hardness. The tablet hardness is 
directly proportional to the disintegration time, in the same time it 
was concluded that the calculated tablet total porosity does not 
have any significant effect on the disintegration time. 
 
In-vitro dissolution  
The dissolution results were satisfactory for most of the studied 
formulae as shown in table (5). The enhanced dissolution is 
related to the use of hydrophilic excipients which ensure 
wettability as well as rapid uptake of water. Formulae 7, 12, 13, 19 
and 20 showed higher dissolution rate (>90%) among all the 
studied formulas.  Dissolution was highly affected by hardness. 
Tablet hardness is inversely proportional to the dissolution rate. 
The main advantage of using water as granulating liquid is 
enhancing the hydrophilization of the miconazole nitrate and 
hence enhancing the dissolution. Lerk et al demonstrated that, the 
release of hydrophobic drugs can be improved by hydrophilization 
process. The hydrophilization was done by creation of hydrophilic 
surface on the drug [36]. Previous work demonstrated that, the 
solubility of miconazole nitrate could be enhanced by water 
soluble excipients [34].  
 
Tablet surface scanning with SEM 
Figure (4) shows surface scan of various miconazole ODT, where 
there existed many 
empty spaces between the granules throughout the tablet in 
which water could be absorbed by capillary forces. It is these 
pores that increase the absorption of water by capillary forces 
which may explain the fast disintegration time noticed for F12. 
F12 contains croscarmelose sodium as super disintegrant which 
characterized by rapid swelling and wicking. The low hardness of 
the tablets (25N) result in relatively high total porosity (34.6%) and 
this is confirmed by SEM micrograph. The pore size may be 
characterized according to the opening size; macropores (pores 
with openings exceeding 500Ao), micropore (pores with openings 
not exceeding 20Ao) and mesopores (pores with intermediate size 
openings) [37]. The Pore size in F12 was measured from SEM 
micrograph, the pore diameter was around 30 micron which is 
considered as mesopores. The pores on the tablet surface were 
characterized by being inter-connected. The porous structure of 
the tablets was the result of the low mannitol content and low 
hardness of the tablets, the pore size measurement is matched 
with the calculated total porosity (relatively high porosity value). 
The pores F13 was shown to be less distributed and smaller in 
size (< 10 micron) and this was confirmed by the calculated total 
porosity (25%).  The decreased in porosity in F13 may be 
explained by the increased in the mannitol content in the tablets, 
the mannitol is compressed by the fragmentation compression 
profile, which may result in less porous structure. Compression of 
mannitol granules using low compression force results in 
decrease pore volume and porosity percentage [38]. Tablets of 
the F19 were compressed to low hardness (25 N), the pores have 
size ranged 20 – 30 micron, and these pores are well distributed 
on the tablet surface. The calculated total porosity is lower than 
that of the F12 but is more than that of F13; these results are 
matching with SEM micrographs analysis. Tablets of the F20 
showed more cracked surface indicates highly porous structure, 
this graph confirm the relatively high calculated total porosity. The 
total porosity of these tablets is maintained although it was 
compressed with relatively high hardness (35 N), but the low 
mannitol content seems to be the predominant factor in the high 
porosity. The disintegration time of this formula was the lowest 
among all the studied formulae (18 seconds) which may be 
explained by the tablet total porosity and its content of MCC, as it 
acts as disintegrant. It was expected that the relatively high 
hardness of the tablets and the used lubricant may have retarding 
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effect on the disintegration time, but the effect of MCC and tablet 
total porosity were more predominant. 
 
In vivo disintegration time 
The results for the in vivo disintegration time graphically illustrated 
in figure (5). It was noted that, most of the in-vivo disintegration 
time results are longer than that of the in-vitro which could be 
explained by the low saliva volume (7 ml) compared to the high 
volume in-vitro testing (700 ml). All the results are complying with 
the European pharmacopeia standard for oral dispersible tablets 
(NMT 3 minutes). 
Analysis and ranking 
Rank order for the effect of various parameters on miconazole 
nitrate granules is shown in table (6). The ranking was done 
based on the relative rank for each variable "based on delta 
value" that was calculated for each parameter during the study. 
The ranking showed that the preparation of miconazole nitrate 
granules by foam granulation was affected by mannitol/MCC ratio, 
disintegrant type and milling parameters. These results indicate 
that, foam granulation process is rugged enough and did not 
affect by impeller speed. The ruggedness of the foam granulation 
process makes it superior to routine wet granulation process. This 
conclusion indicates that, the foam granulation is easily scaled up 
taking in account few scaling issues. Sheskey et al mentioned, the 
binder rate of addition and nozzle placement is among that issues   
[39]. Rank order for the effect of various parameters on 
compression of miconazole nitrate ODT is shown in table (7) in 
which the compression of miconazole nitrate ODT was affected by 







It can be concluded that, miconazole nitrate can be formulated as 
oral disintegrating tablet by foam granulation technique. Testing of 
the prepared miconazole nitrate granules and compressed tablet 
prepared by foam granulation results in a formulation with 
acceptable quality control characters.  
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Table 1: Orthogonal array for miconazole nitrate 50 mg ODT optimization program 
 
FC LT a UC 
% 








MP c GT TH 
"N" 
1 1 3 1 12 30 1 40 2 200 25 
2 1 3 2 9 40 2 60 1 300 35 
3 1 3 3 6 50 3 80 4 380 45 
4 1 3 4 3 60 4 100 3 R972 55 
5 1 6 1 12 40 2 80 4 R972 55 
6 1 6 2 9 30 1 100 3 380 45 
7 1 6 3 6 60 4 40 2 300 35 
8 1 6 4 3 50 3 60 1 200 25 
9 1 9 1 9 50 4 40 1 380 55 
10 1 9 2 12 60 3 60 2 R972 45 
11 1 9 3 3 30 2 80 3 200 35 
12 1 9 4 6 40 1 100 4 300 25 
13 1 12 1 9 60 3 80 3 300 25 
14 1 12 2 12 50 4 100 4 200 35 
15 1 12 3 3 40 1 40 1 R972 45 
16 1 12 4 6 30 2 60 2 380 55 
17 2 3 1 3 30 4 60 4 300 45 
18 2 3 2 6 40 3 40 3 200 55 
19 2 3 3 9 50 2 100 2 R972 25 
20 2 3 4 12 60 1 80 1 380 35 
21 2 6 1 3 40 3 100 2 380 35 
22 2 6 2 6 30 4 80 1 R972 25 
23 2 6 3 9 60 1 60 4 200 55 
24 2 6 4 12 50 2 40 3 300 45 
25 2 9 1 6 50 1 60 3 R972 35 
26 2 9 2 3 60 2 40 4 380 25 
27 2 9 3 12 30 3 100 1 300 55 
28 2 9 4 9 40 4 80 2 200 45 
29 2 12 1 6 60 2 100 1 200 45 
30 2 12 2 3 50 1 80 2 300 55 
31 2 12 3 12 40 4 60 3 380 25 
32 2 12 4 9 30 3 40 4 R972 35 
FC: Formula code, LT: lubricant type, UC: Urea Concentration, D: Disintegrant, TD: total disintegrant, I.D: Intragranular disintegrant, M: 
Mannitol, MCC: Microcrystalline cellulose, IS: Impeller Speed, MP: Milling Parameters, GT: glidant type (Aerosil), and TH: tablet hardness. 
a: Lubricant: (1) Sodium lauryl sulfate (Hydrophilic) vs (2) Magnesium Stearate (Hydrophobic). b: Disintegrant :(1) Explotab low pH, (2) 
Explotab High pH, (3) Plasdone XL10, (4) Croscarmelose sodium. c: Milling parameters: (1) Sieve 500 micron speed 2000 rpm, (2) Sieve 500 
micron speed 1000 rpm, (3) Sieve 1000 micron speed 2000 rpm and (4) Sieve 1000 micron speed 1000 rpm. 
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F1 0.41 0.52 22 262.9 1.69 1.46 
F2 0.34 0.46 26 223.3 1.69 1.35 
F3 0.43 0.59 28 460.4 1.68 1.48 
F4 0.37 0.49 26 216.4 1.69 1.48 
F5 0.42 0.51 18 241.0 1.62 1.22 
F6 0.41 0.53 22 209.2 1.70 1.37 
F7 0.33 0.52 37 386.6 1.67 1.33 
F8 0.38 0.56 33 547.3 1.69 1.34 
F9 0.41 0.57 29 257.2 1.70 1.30 
F10 0.38 0.51 26 248.2 1.69 1.36 
F11 0.39 0.57 31 437.4 1.68 1.38 
F12 0.36 0.49 26 390.4 1.68 1.31 
F13 0.40 0.52 24 358.4 1.69 1.27 
F14 0.45 0.55 19 285.6 1.69 1.36 
F15 0.37 0.52 30 409.6 1.69 1.28 
F16 0.38 0.53 29 048.6 1.68 1.30 
F17 0.35 0.48 28 078.0 1.68 1.34 
F18 0.37 0.48 24 263.0 1.69 1.29 
F19 0.38 0.50 24 544.0 1.69 1.43 
F20 0.40 0.52 23 273.8 1.69 1.38 
F21 0.38 0.52 26 304.3 1.70 1.42 
F22 0.35 0.51 31 270.7 1.69 1.36 
F23 0.37 0.49 24 283.2 1.69 1.43 
F24 0.39 0.52 24 254.0 1.68 1.36 
F25 0.38 0.50 24 213.6 1.69 1.27 
F26 0.37 0.50 25 263.2 1.68 1.34 
F27 0.36 0.55 34 553.0 1.68 1.25 
F28 0.43 0.54 21 317.6 1.69 1.37 
F29 0.45 0.56 20 327.4 1.69 1.35 
F30 0.41 0.56 27 221.4 1.69 1.32 
F31 0.50 0.69 27 451.2 1.67 1.35 
F32 0.42 0.55 24 308.6 1.69 1.37 
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Table 3: Different properties of lubricated miconazole nitrate granules prepared by foam granulation 
 
 







F1 1.9 30.4 110 
F2 1.2 34.6 200 
F3 0.6 37.8 70 
F4 1.7 31.5 85 
F5 1.9 26.9 100 
F6 1.7 28.8 50 
F7 0.7 41.2 80 
F8 0.7 38.4 50 
F9 1.3 35.3 40 
F10 1.7 30.2 55 
F11 0.6 37.6 75 
F12 1.7 31.3 75 
F13 1.0 30.9 60 
F14 1.4 31.6 65 
F15 1.2 31.4 125 
F16 1.2 37.8 75 
F17 0.7 35.7 115 
F18 1.0 29.5 75 
F19 0.8 28.1 180 
F20 0.6 26.6 80 
F21 0.7 33.7 90 
F22 0.9 32.5 115 
F23 0.9 29.5 70 
F24 1.9 26.6 100 
F25 1.3 28.1 140 
F26 0.8 30.6 150 
F27 0.6 38.2 210 
F28 1.2 29.1 130 
F29 1.3 26.4 60 
F30 1.2 30.1 85 
F31 1.1 36.5 55 
F32 1.4 27.3 140 
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1 100.9 3.82 0.73 52.1 0.37 
2 98.0 3.5 0.70 79.6 0.00 
3 109.7 3.17 2.56 113.0 0.02 
4 98.7 2.96 0.88 147.9 0.11 
5 95.5 2.95 0.55 148.4 0.04 
6 98.3 3.06 0.85 117.1 0.03 
7 101.0 3.2 0.92 87.1 0.43 
8 108.7 3.47 2.10 57.4 1.47 
9 96.4 2.88 1.34 152.0 0.00 
10 93.0 3.03 1.51 118.2 0.13 
11 102.9 3.23 1.79 86.3 0.21 
12 100.8 3.53 0.62 56.4 0.45 
13 101.5 3.02 2.10 65.9 0.67 
14 96.4 2.99 1.09 93.2 0.39 
15 100.2 2.85 1.12 125.7 0.00 
16 103.8 2.75 0.97 159.2 0.03 
17 102.0 3.4 1.24 105.4 1.04 
18 95.5 3.05 0.71 143.6 0.00 
19 97.9 3.76 0.95 52.9 0.44 
20 96.6 3.52 1.70 79.2 0.18 
21 100.1 3.55 0.90 78.5 0.44 
22 105.9 3.61 1.11 55.1 0.39 
23 91.3 3.05 0.92 143.6 0.05 
24 104.5 3.14 1.09 114.1 0.34 
25 94.5 3.25 0.55 85.7 0.15 
26 97.6 3.45 1.11 57.7 0.22 
27 101.9 3.07 1.39 142.6 0.10 
28 99.4 3.05 0.99 117.5 0.15 
29 99.5 2.96 1.47 121.0 0.18 
30 93.1 2.8 0.49 156.4 0.00 
31 100.4 3.4 0.77 58.5 0.00 
32 95.6 2.82 1.15 98.8 0.16 
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Table 5: Tablet wetting time, water absorption ratio, calculated true density, calculated total porosity of 






















F1 65 53.6 1.567 36 44.8 60 
F2 100 85.5 1.555 29 50.6 55 
F3 120 29.3 1.529 20 76.8 45 
F4 60 69.2 1.544 16 55.7 92 
F5 44 21.8 1.554 18 77.3 125 
F6 110 53.8 1.568 22 72.3 80 
F7 130 22.4 1.525 23 92.0 165 
F8 130 41.6 1.548 30 82.1 51 
F9 60 13.9 1.544 19 80.2 145 
F10 45 37.7 1.548 23 82.3 100 
F11 40 51.7 1.546 27 47.1 105 
F12 35 59.5 1.568 35 94.4 40 
F13 30 10.7 1.548 25 98.5 35 
F14 50 36.1 1.544 24 51.9 95 
F15 130 28.7 1.559 21 42.3 93 
F16 26 11.3 1.554 18 53.7 105 
F17 45 12.5 1.544 26 57.2 50 
F18 130 17.5 1.548 18 75.2 125 
F19 130 45.0 1.526 33 100.0 35 
F20 60 143.1 1.567 30 100.0 18 
F21 120 39.7 1.548 32 55.1 45 
F22 200 66.5 1.544 33 83.5 50 
F23 180 30.2 1.539 20 59.4 85 
F24 25 18.9 1.554 23 78.3 50 
F25 65 50.1 1.568 29 62.8 54 
F26 150 36.4 1.555 33 62.1 60 
F27 200 19.7 1.509 22 38.1 130 
F28 60 20.9 1.544 23 46.6 85 
F29 120 22.9 1.555 24 52.3 120 
F30 190 27.8 1.569 20 48.5 100 
F31 200 17.8 1.505 32 74.7 40 
F32 24 16.0 1.548 20 45.2 97 
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Table 6: Ranking of the variables affecting the formulation and processing of miconazole nitrate granules 




ER CI AOR FR WT sum Rank 
Urea conc. 6 7 1 7 7 2 2 32 4 
D.  type 1 6 4 1 1 4 8 25 3 
D.  conc. 7 1 6 3 3 6 7 33 5 
Intragranular  D 
conc. 
4 5 3 4 8 7 4 35 6 
Mannitol/MCC ratio 2 2.5 7 5 2 1 3 22.5 1 
Impeller speed 3 4 5 6 6 5 9 38 7 
Milling parameters 5 2.5 2 2 5 3 5 24.5 2 
VMD = volume mean diameter, GMSD = geometric mean standard deviation, ER =elongation ratio, CI = Carr's index, AOR = 







Table 7: Ranking of the variables affecting the quality control parameters of miconazole nitrate ODT 
prepared by foam granulation 
 
Variable WV TS F DIS DT WTT WAR TP sum Rank 
Urea conc. 7 1 4 4 2 5 1 2 26 2 
D  type 4 4 6 6 5 1 5 7 38 5 
D. conc. 8 5 3 2 8 7 7 4 44 7 
Mannitol/MCC 
ratio 
1 7 5 7 3 6 2 3 34 4 
Milling 
parameters 
3 6 7 5 7 3 4 5 40 6 
Lubricant 6 3 8 8 6 2 8 5 46 8 
Aerosil type - 2 2 3 4 8 6 8 33 3 
Hardness 2 - 1 1 1 4 3 1 13 1 
WV=Weight variation, TS=Tensile strength, F=Friability, DIS=Dissolution, TP=Tablet porosity, DT=Disintegration time, 
WTT=Wetting time tablets, WAR=Water absorption ratio, D=disintegrant 
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Figure 1: DSC chromatogram of pure miconazole nitrate (A), physical blend of miconazole nitrate and 
hydroxy propyl methylcellulose at ratio 10:1 (B), and physical blend of miconazole nitrate and magnesium 
stearate at ratio 10:1(C) 
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Figure 2: The IR spectrum of miconazole nitrate (A), IR spectrum of miconazole nitrate : Sodium lauryl 
sulfate at ratio 1 : 0.1 (B), IR spectrum of miconazole nitrate : mannitol at ratio 1: 1 (C) 
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Disintegration 
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